Clinical Trial Transparency Archives - Page 3 of 3 - TrialAssure

Feature image

REGISTRY SNAPSHOT: Central Committee on Research Involving Human Subjects (CCMO)

by Staff Writer | January 2019

Posted in Snapshots

Read More

Feature image

This week in transparency news: December 22, 2018 – January 4, 2019

by Staff Writer | January 2019

Posted in Blog

Read More

The FDA issued a draft guidance in September 2018 to detail the regulatory body’s thinking on monetary penalties of up to $10,000 per day for failing to register a clinical trial, patterns of previous noncompliance, and/or submitting misleading or false information to ClinicalTrials.gov. While the FDA has not previously begun issuing fines to pharmaceutical companies, this guidance brings that reality one step closer. Zach Weingarden, Product Solutions Manager, TrialAssure, helps clarify some common questions on this draft guidance that sponsors and other partners have been asking. Zach Weingarden, Product Solutions Manager, TrialAssure

Common clinical trial transparency questions, answered!

by Staff Writer | November 2018

Posted in Blog

Read More

trialassure clinical trial transparency news

This week in transparency news: September 8-14, 2018

by Staff Writer | September 2018

Posted in Blog

Read More

trialassure clinical trial transparency news

This week in transparency: August 18 – August 24, 2018

by Staff Writer | August 2018

Posted in Blog

Read More

bioethics international good pharma scorecard gps disclosure clinical trial transparency trialassure

This week in transparency news: July 7 – July 13, 2018

by Staff Writer | July 2018

Posted in Blog

Read More

bioethics international good pharma scorecard gps disclosure clinical trial transparency trialassure

Good Pharma Scorecard: Improvements Seen in Clinical Trial Transparency Compliance

by Staff Writer | January 2018

Posted in Blog

Read More

Get in Touch